Kiniksa Pharmaceuticals International, plc (KNSA) stock
KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 14/30461% above fair value
$95.11+0.88 (+0.93%)
Close on Nov 17, 2026Market cap $14.95BP/E 73.2Yield –
Kiniksa Pharmaceuticals International profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Kiniksa Pharmaceuticals International's profit margin for the twelve months ending Sep 30, 2026 was 11.6%. For fiscal 2025 it was 8.7%, against -10.2% the year before. The highest annual figure on record is 83.3% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.7% | +18.9 |
| FY2024 | Dec 31, 2024 | -10.2% | −15.4 |
| FY2023 | Dec 31, 2023 | 5.2% | −78.1 |
| FY2022 | Dec 31, 2022 | 83.3% | +493.0 |
| FY2021 | Dec 31, 2021 | -409.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 16.6% | +6.4 |
| Q2 FY2026 | Jun 30, 2026 | 10.4% | −0.9 |
| Q1 FY2026 | Mar 31, 2026 | 10.5% | +4.3 |
| Q4 FY2025 | Dec 31, 2025 | 7.0% | +14.3 |
| Q3 FY2025 | Sep 30, 2025 | 10.2% | +21.5 |
| Q2 FY2025 | Jun 30, 2025 | 11.4% | +15.0 |
| Q1 FY2025 | Mar 31, 2025 | 6.2% | +28.4 |
| Q4 FY2024 | Dec 31, 2024 | -7.3% | −37.5 |
| Q3 FY2024 | Sep 30, 2024 | -11.3% | +9.4 |
| Q2 FY2024 | Jun 30, 2024 | -3.6% | −24.5 |
| Q1 FY2024 | Mar 31, 2024 | -22.2% | +3.2 |
| Q4 FY2023 | Dec 31, 2023 | 30.3% | +23.1 |
| Q3 FY2023 | Sep 30, 2023 | -20.7% | −246.7 |
| Q2 FY2023 | Jun 30, 2023 | 20.9% | +95.0 |
| Q1 FY2023 | Mar 31, 2023 | -25.4% | +52.9 |
| Q4 FY2022 | Dec 31, 2022 | 7.2% | +201.0 |
| Q3 FY2022 | Sep 30, 2022 | 226.0% | +478.6 |
| Q2 FY2022 | Jun 30, 2022 | -74.1% | +465.4 |
| Q1 FY2022 | Mar 31, 2022 | -78.3% | – |
| Q4 FY2021 | Dec 31, 2021 | -193.8% | – |
| Q3 FY2021 | Sep 30, 2021 | -252.5% | – |
| Q2 FY2021 | Jun 30, 2021 | -539.5% | – |
See a number that looks wrong?